Genevieve M. Gerhard

1 ta ish

Harvard University

1. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

   Bryan D. Choi, Xiaoling Yu, Ana P. Castaño +14

   MaqolaOAOchiq kirish20192 iqtibos

   ABIABI:AkademIndex/2026.other.020532